Rees, C. A., Brousseau, D. C., Ahmad, F. A., Bennett, J., Bhatt, S., Bogie, A., … SCD Arginine Study Group and PECARN. (2022). Adherence to NHLBI guidelines for the emergent management of vaso-occlusive episodes in children with sickle cell disease: A multicenter perspective. Am J Hematol, 97(11), E412–E415. https://doi.org/10.1002/ajh.26696

Rees, Chris A., David C. Brousseau, Fahd A. Ahmad, Jonathan Bennett, Seema Bhatt, Amanda Bogie, Kathleen M. Brown, et al. “Adherence to NHLBI guidelines for the emergent management of vaso-occlusive episodes in children with sickle cell disease: A multicenter perspective.” Am J Hematol 97, no. 11 (November 2022): E412–15. https://doi.org/10.1002/ajh.26696.

Rees CA, Brousseau DC, Ahmad FA, Bennett J, Bhatt S, Bogie A, et al. Adherence to NHLBI guidelines for the emergent management of vaso-occlusive episodes in children with sickle cell disease: A multicenter perspective. Am J Hematol. 2022 Nov;97(11):E412–5.

Rees, Chris A., et al. “Adherence to NHLBI guidelines for the emergent management of vaso-occlusive episodes in children with sickle cell disease: A multicenter perspective.” Am J Hematol, vol. 97, no. 11, Nov. 2022, pp. E412–15. Pubmed, doi:10.1002/ajh.26696.

Rees CA, Brousseau DC, Ahmad FA, Bennett J, Bhatt S, Bogie A, Brown KM, Casper TC, Chapman LL, Chumpitazi CE, Cohen DM, Dampier C, Ellison AM, Grasemann H, Hickey RW, Hsu LL, Lane PA, Bakshi N, Leibovich S, Patil P, Powell EC, Richards R, Sarnaik S, Weiner DL, Morris CR, SCD Arginine Study Group and PECARN. Adherence to NHLBI guidelines for the emergent management of vaso-occlusive episodes in children with sickle cell disease: A multicenter perspective. Am J Hematol. 2022 Nov;97(11):E412–E415.